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a b s t r a c t
The primary site for life-long latency of bovine herpesvirus 1 (BHV-1) is sensory neurons. The
synthetic corticosteroid dexamethasone consistently induces reactivation from latency; however the
mechanism by which corticosteroids mediate reactivation is unclear. In this study, we demonstrate for
the ﬁrst time that dexamethasone stimulates productive infection, in part, because the BHV-1 genome
contains more than 100 potential glucocorticoid receptor (GR) response elements (GREs). Immediate
early transcription unit 1 (IEtu1) promoter activity, but not IEtu2 or VP16 promoter activity, was
stimulated by dexamethasone. Two near perfect consensus GREs located within the IEtu1 promoter
were necessary for dexamethasone-mediated stimulation. Electrophoretic mobility shift assays and
chromatin immunoprecipitation studies demonstrated that the GR interacts with IEtu1 promoter
sequences containing the GREs. Although we hypothesize that DEX-mediated stimulation of IEtu1
promoter activity is important during productive infection and perhaps reactivation from latency,
stress likely has pleiotropic effects on virus-infected cells.
& 2015 Elsevier Inc. All rights reserved.
Introduction
Acute infection of cattle with bovine herpesvirus 1 (BHV-1) results
in clinical disease within the upper respiratory tract, nasal cavity, and
ocular cavity. The ability of BHV-1 to immune-suppress infected cattle
can lead to secondary bacterial infections and life-threatening pneu-
monia, reviewed by Jones (1998, 2003, 2009), Jones et al. (2006), Jones
and Chowdhury (2007). Consequently, BHV-1 is a signiﬁcant cofactor
of bovine respiratory disease complex, a poly-microbial disorder that
is the most important disease in cattle. Following acute infection of
calves, BHV-1 establishes latency in sensory neurons. Periodically,
reactivation from latency occurs, which is crucial for virus tran-
smission.
During productive infection of cultured cells, BHV-1 gene expres-
sion is temporally regulated in three distinct phases: immediate early
(IE), early (E), or late (L), reviewed by Jones (1998, 2003). IE gene
expression is stimulated by a virion component, VP16 (Misra et al.,
1994, 1995). Two BHV-1 IE transcription units exist: IE transcription
unit 1 (IEtu1) and IEtu2 (Wirth et al., 1992, 1989, 1991). IEtu1 encodes
functional homologues of two herpes simplex virus type 1 (HSV-1)
transcriptional regulatory proteins, ICP0 and ICP4 (bICP0 and bICP4,
respectively). The IEtu1 promoter regulates IE expression of bICP4
and bICP0. The bICP0 protein is translated from an IE (IE2.9) or an E
mRNA (E2.6) because both the IEtu1 promoter and E promoter
regulate bICP0 RNA expression (Fraefel et al., 1994; Wirth et al.,
1992, 1989, 1991). Expression of the bICP4 protein represses IEtu1
promoter activity whereas bICP0 activates its own E promoter and all
other viral promoters. IEtu2 expresses a 1.7 kb IE and L transcript that
encodes bICP22, which has been reported to repress viral promoters
in transient transfection assays (Koppel et al., 1997; Schwyzer et al.,
1994).
Stress, due to deprivation of food and water during shipping of
cattle, weaning, or dramatic weather changes increases corticosteroid
levels and the incidence of BHV-1 reactivation from latency, reviewed
by Jones et al. (2011), Jones and Chowdhury (2007), Perng and Jones
(2010). A single IV injection of the synthetic corticosteroid dexa-
methasone (DEX) induces BHV-1 reactivation from latency 100% of
the time (Inman et al., 2002a; Jones, 1998, 2003; Jones et al., 2006,
2000; Rock et al., 1992) suggesting this natural host model can
enhance our understanding of steps that occur during early stages
of reactivation from latency in vivo, which we have coined the escape
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
http://dx.doi.org/10.1016/j.virol.2015.06.010
0042-6822/& 2015 Elsevier Inc. All rights reserved.
n Corresponding author.
E-mail address: clint.jones10@okstate.edu (C. Jones).
1 Current address: Oklahoma State University, Center for Veterinary Health,
Department of Pathobiology, Stillwater, OK 74078.
Virology 484 (2015) 377–385
from latency (Frizzo da Silva et al., 2013). DEX also accelerates
reactivation from latency in TG neuronal cultures or TG organ cultures
prepared from mice latently infected with HSV-1 (Du et al., 2012;
Halford et al., 1996). Canine herpesvirus type 1, another α-her-
pesvirinae subfamily member, consistently reactivates from latently
infected beagles following treatment with the synthetic corticosteroid
prednisone (Ledbetter et al., 2009). Collectively, these studies indicate
that increased corticosteroids levels, as a result of stressful stimuli, can
increase the frequency of reactivation from latency.
Corticosteroids enter cells and bind to the glucocorticoid receptor
(GR) or mineralocorticoid receptor (MR), reviewed in Oakley and
Cidlowski (2013). The MR or GR dimer bound to a corticosteroid
molecule enters the nucleus and within minutes stimulates transcrip-
tion by binding consensus glucocorticoid receptor response elements
(GRE; 50-GGTACANNNTGTTCT-30) and remodeling chromatin (Giguere
et al., 1986; Wang et al., 2004). Corticosteroids also have anti-
inﬂammatory and immune-suppressive effects, in part by inactivating
transcription factors (AP-1 and NF-κb) that stimulate expression of
inﬂammatory cytokines, reviewed in Rhen and Cidlowski (2005).
Approximately 50% of TG sensory neurons express the GR (DeLeon
et al., 1994) and the MR is also expressed in neurons (Arriza et al.,
1988) suggesting an activated GR and/or MR can inﬂuence reactivation
from latency.
Within 6 h after latently infected calves are treated with DEX, lytic
cycle BHV-1 RNA expression is detected in a subset of trigeminal
ganglionic neurons (Winkler et al., 2002, 2000). Two BHV-1 viral
regulatory proteins, bICP0 and VP16, are expressed in the same neuron
within 90 min after DEX treatment of latently infected calves; con-
versely two other late proteins (gC and gD) are not readily detected
until 6 h after DEX treatment (Frizzo da Silva et al., 2013). Many
bICP0þ or VP16þ neurons are also GRþ suggesting activation of the
GR by DEX and/or DEX inducible transcription factors stimulate viral
gene expression. Two transcription factors, promyelocytic leukemia
zinc ﬁnger (PLZF) and Slug are induced more than 15-fold 3 h after
DEX treatment and stimulate BHV-1 productive infection (Workman
et al., 2012). Five additional DEX induced cellular transcription factors
were identiﬁed in TG, and they stimulate productive infection and
certain key viral promoters, including the IEtu1 and bICP0 early
promoters (Workman et al., 2012). A subset of these DEX inducible
transcription factors also stimulate HSV-1 ICP0 promoter activity and
are induced in TG neurons of mice following explant (Sinani et al.,
2013a) suggesting certain common stress-induced cellular transcrip-
tion factors can stimulate HSV-1 and BHV-1 reactivation from latency.
In this study, we provide evidence for the ﬁrst time that BHV-1
productive infection is directly stimulated by DEX. More than 100
potential GREs are present in the BHV-1 genome, including 15 GREs
within the repeat sequences, which encode viral transcriptional
regulatory proteins and origin of replication (ORIS). Two GRE-like
motifs were present in the IEtu1 promoter, and sequences containing
these GREs are crucial for stimulation by DEX. Mutagenesis of
individual GRE motifs indicated that GRE#1 was more important than
GRE#2: however, both GREs were necessary for optimal trans-
activation. Additional studies indicated that the GR directly interacts
with sequences containing GRE#1 and GRE#2. In contrast to the IEtu1
promoter, the BHV-1 VP16 and IEtu2 promoters were not stimulated
by DEX. These studies suggest that activation of the GR by DEX or
natural corticosteroids can directly stimulate productive infection
because the BHV-1 genome contains multiple GREs.
Results
DEX stimulates productive infection in cultured bovine cells
Based on previous studies demonstrating that increased corti-
costeroids consistently induce BHV-1 reactivation from latency,
reviewed by Jones (2013), Jones et al. (2011), we hypothesized that
corticosteroids directly stimulate viral gene expression and pro-
ductive infection. To test whether DEX has an effect on productive
infection, BHV-1 genomic DNA was cotransfected with a plasmid
expressing the mouse GR into primary bovine kidney (BK) cells
and the effects of DEX measured. This approach was used instead
of infecting cells because we were concerned that VP16, which is
part of an infectious viral particle, would over-ride any effect DEX
has on stimulating viral gene expression in permissive cells. For
these studies, we used the gCblue BHV-1 recombinant that
contains the Lac Z gene downstream of the gC promoter. Since
the mammalian GR and corticosteroid signaling pathways
are highly conserved (Oakley and Cidlowski, 2013; Rhen and
Cidlowski, 2005), the use of a mouse GR was appropriate.
Twenty-four hours after transfection was used because this
time-point minimized fusion of individual β-galactosidase positive
cells (Geiser et al., 2002; Geiser et al., 2003; Inman et al., 2001a,
2001b, 2002b; Meyer et al., 2007). DEX stimulated BHV-1 produc-
tive infection approximately three-fold, which was signiﬁcantly
different relative to the negative control (Fig. 1). DEXþthe GR
expression plasmid stimulated productive infection but not more
than DEX alone indicating that the GR signaling pathway is
functional in BK cells.
The results in Fig. 1 suggested that GREs located in the BHV-1
genome are important with respect to DEX stimulating productive
infection. Consequently, potential GREs in the BHV-1 genome were
identiﬁed using the TRANSFAC program and manual inspection by
comparing to known GREs (Matys et al., 2006). The BHV-1 genome
contains 75 potential GREs on the positive strand and negative strand
at the same location, which is due to the palindromic nature of the
GRE (Supplemental Fig. 1A). Twenty-one and 18 “unique” sites (i.e. not
identiﬁed on the opposite strand) were identiﬁed on the positive and
negative strands, respectively. Fifty-ﬁve of the total GREs were located
in coding sequences. IETu1 promoter sequences (Misra et al., 1994),
which drive expression of bICP0 and bICP4 (Wirth et al., 1992), contain
GREs that are referred to as GRE#1 and GRE#2. GRE#2 contains two
partially over-lapping GREs (Supplemental Fig. 1B and Fig. 2A).
IEtu1 promoter activity is stimulated by the activated GR
The IEtu1 and IEtu2 promoters were examined for their ability
to be stimulated by DEX. Three IEtu1 promoter constructs shown
Fig. 1. DEX stimulates productive infection. Bovine kidney (BK) cells were incu-
bated in 2% “stripped” fetal bovine serum for 24 h to reduce cortisol levels present
in serum. BK cells were transfected with 0.5 μg BHV-1 gC-Blue and where indicated
a plasmid that expresses the mouse GR protein. To maintain the same amount of
DNA in each sample, empty vector was included in samples not transfected with
the GR plasmid. Designated cultures were then treated with water soluble DEX
(10 μM; Sigma). At 24 h after transfection, the number of β-Galþ cells was counted.
The value for the Control (gC-Blue virus treated with PBS after transfection) was set
at 1. The results from DEX treated cultures were compared to the Control and are an
average of three independent studies. The asterisk denotes a signiﬁcant difference
between the Control (po0.05) using the Students t test.
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in Fig. 2A were cotransfected with a plasmid that expresses the
human GR fused to GFP and certain cultures treated with DEX. The
use of the GR-GFP fusion allowed us to readily conﬁrm that
nuclear translocation of GR occurred following DEX treatment
(data not shown). Furthermore, mouse neuroblastoma cells
(Neuro-2A) do not respond well to DEX stimulation; but they
can be readily transfected and following serum withdrawal they
differentiate and sprout neurites (Sinani et al., 2013b, 2014)
conﬁrming they have certain neuronal features. IEtu1cat, but not
IEtu1catΔ831 or IEtu1catΔ1018, was stimulated approximately
8 fold by DEX treatment (Fig. 2B), which was signiﬁcantly different
compared to promoter activity in cultures not treated with DEX
(po0.001). An IEtu2 promoter construct (genomic coordinates
111,483–111,861) is trans-activated by VP16 (Koppel et al., 1997)
and contains 2 putative GR sites. IEtu2 promoter activity was not
stimulated by DEX; but promoter activity was consistently red-
uced 2-fold following DEX treatment (Fig. 2B). The mouse mam-
mary tumor virus (MMTV) LTR was used as a positive control
because it contains multiple GREs (Chandler et al., 1986; Kuhnel
et al., 1986), and as expected was stimulated approximately 40 fold
by DEX (Fig. 2C).
The late viral promoter, VP16, was also examined because this
protein is detected at early times during reactivation from latency
(Frizzo da Silva et al., 2013). Furthermore, during heat stress-induced
reactivation from latency, HSV-1 encoded VP16 has been proposed to
initiate reactivation from latency (Kim et al., 2012; Thompson et al.,
2009). Since VP16 selectively activates IE gene expression (O’Hare,
1993; O’Hare and Goding, 1988; O’Hare and Hayward, 1985), stress-
induced stimulation of VP16 promoter activity could stimulate viral
gene expression during productive infection or early phases of
reactivation from latency. A BHV-1 VP16 promoter construct contain-
ing sequences spanning 547 to þ207 from the initiating ATG of the
ORF was not stimulated by DEX (Fig. 2B).
Localization of GR responsive sequences in the IEtu1 promoter
Additional studies were performed to localize the DEX responsive
region within the IEtu1 promoter. The 831 base pairs missing from
IEtu1catΔ831 contain GRE#1 and GRE#2 and were predicted to
contain the DEX responsive region (DRR) (Fig. 3A and B). All
nucleotides in GRE#1 match the required or preferred nucleotides
in the consensus GRE (Fig. 3C). GRE#2 contains a single mismatch
(denoted by the underlined gray nucleotide) compared to the GRE
consensus. The SV40 E promoter construct containing the DRR and 30-
DRR construct, but not the 50-DRR construct, were stimulated
approximately 20 fold by DEX (Fig. 3D, black columns) compared to
cultures not treated with DEX (white columns), which was statistically
signiﬁcant (po0.005).
When GRE#1 was disrupted and an EcoRI site inserted (30-
DRRΔGRE#1; see Fig. 3C for wt and mutated sequence), this construct
was stimulated by DEX only 2 fold (Fig. 3D, black columns), which
was not signiﬁcantly different than the empty pCAT3-promoter.
When GRE#2 was deleted and replaced by an EcoRI site (30-
DRRΔGRE#2), this construct was stimulated approximately 6 fold
by DEX, which was signiﬁcantly different than cultures not treated
with DEX (po0.005). The construct in which both putative GREs
were mutated (30-DRRΔ2xGRE) was not stimulated by DEX. As
expected, the MMTV LTR was stimulated by DEX more than 40 fold
in these studies (Fig. 3E). These studies indicated that: (1) GRE#1 was
more important than GRE#2 with respect to stimulation by DEX, and
(2) optimal DEX stimulation required GRE#1 and GRE#2.
Interaction of cellular factors with IEtu1 promoter sequences
containing GRE#1 and GRE#2
Electrophoretic mobility shift assays (EMSA) were performed to
test whether cellular factors interact with GRE#1 and GRE#2. Two
distinct shifted radioactive bands were detected when a commercially
available oligonucleotide containing a consensus GRE was incubated
with cell lysate prepared from Neuro-2A cells (Fig. 4A); conversely
only one shifted band was present when an oligonucleotide contain-
ing a mutated GRE was incubated with cell lysate (Fig. 4A). One
shifted band (denoted by the closed circle) was more intense when
cell lysate was prepared from Neuro-2A cells transfected with the GR
encoding plasmid compared to the other samples (Fig. 4A, lane 4). An
oligonucleotide spanning GRE#1, but not the GRE#1 mutant oligo-
nucleotide, contained two shifted bands following incubation with
cell lysate prepared from Neuro-2A cells (Fig. 4B). Addition of DEX
(lanes 3 and 5) did not increase binding to the consensus GRE or
GRE#1, which may be due to the ﬁnding that when cells are lysed the
GR can speciﬁcally bind DNA and activate transcription in the absence
of corticosteroids (Schmitt and Stunnenberg, 1993). Shifted bands
were not readily detected when GRE#2 (wt or mutant) was incubated
with cell lysate from Neuro-2A cells (Fig. 4C), which was surprising
because there is only one mismatched nucleotide in GRE#2 compared
to the consensus (Fig. 3C).
Low levels of non-radioactive competitor GRE#1 (lane 3,
6 pmol for example) reduced binding of nuclear factors to the
radioactive GRE#1 probe (Fig. 4D). Conversely, the GRE#1 mutant
oligo required at least 20 fold higher concentrations of cold
competitor to reduce binding (lane 7, 120 pmol). The consensus
GRE oligonucleotide also reduced binding to GRE#1 but was not
Fig. 2. IEtu1 promoter activity is stimulated by GR following DEX treatment. Panel
A: The full length IEtu1 promoter is designated IEtu1cat and was cloned as an XhoI-
SphI restriction site. Start site of transcription (arrow), TATA box, binding site for
VP16/Oct1 denoted as TAATGARAT (Misra et al., 1994), and location of putative
GRE#1 and GRE#2 (black and grey rectangles respectively) are shown. The
numbers are genomic coordinates of the ﬁrst nucleotide of each respective motif
or restriction enzyme site. Panel B: Neuro-2A cells were cultured in 2% charcoal
stripped fetal calf serum after transfection with the designated IEtu1 promoter
constructs (2 μg DNA), IEtu2 promoter (2 μg DNA), or a VP16 promoter (2 μg DNA)
fused to CAT and an expression plasmid that expresses the human GR (0.5 μg DNA).
Panel C: Neuro-2A cells were cotransfected with a MMTV LTR cat construct and the
human GR construct. CAT activity was measured using standard CAT-assays at 48 h
after transfection (Workman et al., 2009, 2012). For panels B and C, 24 h after
transfection the designated Neuro-2A cultures were treated with water-soluble
DEX (10 μM; Sigma) (black columns). White columns indicate basal promoter
activity derived from cultures not treated with DEX (see below). The results are the
average of 3 independent experiments. An asterisk denotes signiﬁcant differences
(po0.05) in promoter activity of cells treated with DEX compared to cells not
treated with DEX, as determined by the Student t test.
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quite as efﬁcient as the cold competitor GRE#1 (Fig. 4E). However,
the consensus GRE was more efﬁcient than the GRE#1 mutant
oligonucleotide.
To directly test whether the GR was bound to IEtu1 promoter
sequences, chromatin immunoprecipitation (ChIP) studies were
performed in Neuro-2A cells transfected with IEtu1Cat. This
approach was used because “super-shift” assays did not consis-
tently reveal novel shifted bands following incubation of the
commercially available GRE probe or oligonucleotide containing
GRE#1 and the GR antibody with extracts from Neuro-2A cells
(data not shown). Aliquots of isolated chromatin from Neuro-2A
cells were subjected to ChIP using a GR speciﬁc antibody. Primer
sets that speciﬁcally amplify the GREs (GRE1x yields a 224 bp
product and GRE2x yields a 543 bp product, Fig. 5A) were used to
amplify DNA immunoprecipitated by the GR antibody (Fig. 5B, GR
IP panel). We detected the GR associated with a DNA fragment that
spans GRE#1 (lanes #1) and a fragment spanning both GREs (lane
#2), because primers speciﬁcally ampliﬁed that region. In contrast,
the primer set that ampliﬁes the TATA box region did not yield a
PCR product (Fig. 5B, lanes # 3) indicating the GR was not bound to
this region. In samples transfected with IEtu1cat promoter that
lacks both GREs (IEtu1catΔ831), the GR antibody did not immun-
precipitate DNA that was ampliﬁed by the respective primer sets.
As expected, mock-transfected cells also did not contain ampliﬁed
products using any of the respective probes following immuno-
precipitation with the GR antibody. An isotype control antibody
did not speciﬁcally immunoprecipitate viral DNA that was ampli-
ﬁed by the respective primers (Fig. 5C). PCR performed with non-
immunoprecipitated samples (Fig. 5D) yielded the expected size
amplicon when chromatin was derived from samples transfected
with the IEtu1cat promoter (GRþ IE1 and GRþ IE1 DEX samples).
In summary, EMSA studies demonstrated that cellular factors
speciﬁcally bind to GRE#1 sequences and ChIP analysis revealed
that GREs present in the IEtu1 promoter were bound by the GR.
Examination of GR protein expression in Neuro-2A following DEX
treatment
Steady state GR protein levels were measured because increased
binding to IEtu1 promoter sequences containing GRE#1 and GRE#2
were not observed following DEX treatment (Figs. 4 and 5). Reduced
levels of endogenous GR were detected after Neuro-2A cells were
treated with DEX (Fig. 6A), which was consistent with an independent
study (Nishimura et al., 2014). The GR-GFP fusion protein (denoted by
the closed circle) was not dramatically reduced, in part because the
human CMV IE promoter drives GR expression. Regardless of treat-
ment, tubulin levels were similar in all cells. We suggest that GR levels
are reduced following DEX treatment to prevent constitutive corti-
costeroid signaling.
It is also possible that DEX treatment did not lead to enhanced
binding to a GRE because low levels of GR were present in a subset of
nuclei following stripped serum treatment. To test this prediction,
confocal microscopy was performed following treatment of Neuro-2A
cells with stripped fetal calf serum. As expected, all Neuro-2A cells
grown in the presence of fetal calf serum contained nuclear GR
(Fig. 6B). Treatment with 2% stripped fetal calf serum clearly increased
the levels of cytoplasmic GR and many nuclei did not contain
detectable GR. It was also clear that a low percent of nuclei were still
GR positive after incubation with stripped FBS. DEX treatment led to
nuclear translocation of GR in all nuclei, which is consistent with
hormone activation of the GR, reviewed by Oakley and Cidlowski
(2013), Rhen and Cidlowski (2005). These results indicated that steady
state levels of endogenous GR decrease following DEX treatment and
that a low percent of GRþ nuclei were detected following incubation
of cultures with stripped FBS.
Discussion
More than 100 GRE like motifs were identiﬁed within the BHV-1
genome and the presence of these GREs correlate with DEX-mediated
stimulation of productive infection. Two GREs within the IEtu1
promoter were important for stimulation by DEX. Conversely, the
GRE like motifs present in the IEtu2 promoter were not trans-
activated by the GR suggesting that certain GRE-like motifs in the
BHV-1 genome are not functional. It is also possible that GREs located
in the IEtu2 promoter are only important in the context of productive
Fig. 3. Localization of IEtu1 sequences necessary for DEX-mediated stimulation.
Panel A: Schematic of IEtu1 promoter and location of putative DEX responsive
region (DRR). Panel B: DRR fragments used to localize sequences that are
stimulated by DEX. Location of GRE#1 and GRE#2 are denoted by black or gray
rectangles, respectively. The 30-DRRΔGRE#1 contains a mutation in GRE#1
described in Panel C. The 30-DDRΔGRE#2 contains a mutation in GRE#2 described
in Panel C. The 30-DRRΔ2xGRE contains mutations in GRE#1 and GRE#2. Panel C:
Sequence of consensus GRE. Small letters above a capital letter denotes this
nucleotide is less preferred than nucleotides in capitals. Two small letters denote
that both nucleotides are present in certain consensus sequences but are less
preferred relative to capital letters. N is anything. This consensus was previously
described (Taniguchi-Yanai et al., 2010). The underlined gray nucleotide in GRE#2 is
a mismatch from the consensus GRE. ΔGRE#1 and ΔGRE#2 denote mutations
introduced into GRE#1 and GRE#2. Panel D: Neuro-2A cells were cotransfected
with 2 μg of the designated plasmid construct and 0.5 μg DNA of the plasmid
encoding the human GR. Panel E: Neuro-2A cells were cotransfected with the
pCAT3-promoter or the MMTV LTR (2 μg DNA) construct and the plasmid encoding
the GR (0.5 μg DNA). For these studies, Neuro-2A cells were cultured in 2% charcoal
stripped fetal calf serum after transfection. Twenty-four hours after transfection the
designated Neuro-2A cultures were treated with water soluble DEX (10 μM; Sigma).
CAT activity was measured using standard procedures at 48 h after transfection.
White and black columns indicate the absence and presence of 1.0 μM water-
soluble DEX added to cultures, respectively. The results are the average of
3 independent experiments. An asterisk denotes signiﬁcant differences (po0.05)
in cells transfected with the designated construct in the presence of DEX compared
to the same construct without DEX treatment, as determined by the Student t test.
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infection. Although it is well established that increased corticosteroid
levels stimulate BHV-1 reactivation from latency (Jones, 1998, 2003;
Jones et al., 2011; Jones and Chowdhury, 2007), there are no previous
published reports demonstrating that corticosteroids stimulate BHV-1
productive infection or increase virus shedding during acute infection
of cattle. Since viral RNA and proteins are expressed a few hours after
latently infected calves are treated with DEX (Frizzo da Silva et al.,
2013; Winkler et al., 2002), we hypothesize that corticosteroids
directly stimulate viral gene expression and productive infection. It
will be of interest to identify which viral genes are stimulated by DEX
during productive infection and whether their promoters con-
tain GREs.
During HSV-1 and presumably BHV-1 latency, the viral genome
primarily exists as “silent” chromatin, reviewed by Knipe and Cliffe
(2008), indicating that extensive chromatin remodeling of the viral
genome occurs during early stages of reactivation from latency. In
contrast to many transcription factors, the activated GR can speciﬁcally
bind transcriptionally silent chromatin (Lin and Wrange, 1993;
Perlman, 1992; Perlman and Wrange, 1988) and initiate formation of
a nuclease-hypersensitive site and transcription (Foy and Horz, 2003;
Zaret and Yamamoto, 1984). Interestingly, the activated GR only binds
a subset of GREs in silent chromatin (John et al., 2011; Voss et al.,
2011). These novel properties are consistent with the GR being coined
as a “pioneer transcription factor”, reviewed in Iwafuchi-Doi and Zaret
(2014), Zaret and Carrol (2011). FoxA1, a member of the fork-head
family of DNA binding proteins, is also a pioneer transcription factor
that can target the GR to certain GREs in silent chromatin (Belikov
et al., 2009). The ability of an activated GR to speciﬁcally bind
chromatinized GREs may be important for stimulating productive
infection or reactivation from latency.
Based on our results, we hypothesize that stimulation of IEtu1
promoter activity by an activated GR in latently infected neurons
increases the incidence of reactivation from latency because it drives
expression of bICP0 and bICP4. In addition to GRE#1 and GRE#2 being
important for DEX stimulation, GREs located 2–3 kb upstream of the
IEtu1 promoter may also inﬂuence DEX-mediated stimulation of IEtu1
promoter activity because GREs in cellular chromosomes can be
located 5–19 kb pairs upstream of a promoter and still stimulate
promoter activity (Polman et al., 2012). The 30-DRR fragment that
contains both GREs also contains 3 potential 1/2 GR binding sites (data
not shown). These 1/2 GR binding sites may be relevant in the context
of the viral genome because they can positively or negatively regulate
transcription when bound by the GR (Oakley and Cidlowski, 2013;
Rhen and Cidlowski, 2005).
Although activation of GREs in the IEtu1 promoter is likely to be
important to stimulate productive infection and/or reactivation from
latency, corticosteroids may also have additional effects on infected
cells. For example, DEX-inducible cellular transcription factors identi-
ﬁed in TG neurons can also stimulate viral promoters and productive
infection (Workman et al., 2012). Second, DEX treatment of latently
infected calves induces apoptosis of T cells that persist in TG during
latency (Winkler et al., 2002), which may increase reactivation from
latency because T cells, in particular CD8þ T cells, maintain latency in
small animal models of HSV-1 infection (Decman et al., 2005; Khana
et al., 2004; Knickelbein et al., 2008; Liu et al., 2000). Thus, additional
studies are needed to completely understand the complex virus-host
interactions that regulate stress-induced reactivation from latency.
Materials and methods
Cells and virus
Murine neuroblastoma cells (Neuro-2A) were grown in Eagle’s
minimal essential medium (EMEM) supplemented with 10% FCS,
penicillin (10 U/ml), and streptomycin (100 μg/ml). The designated
Fig. 4. Binding of cellular proteins to GRE-like sequences. Cell lysate was prepared from Neuro-2A cells as described in the materials and methods. Radioactive probes were
prepared from a consensus GRE probe (Santa Cruz Biotechnology) or GRE mutant (Santa Cruz Biotechnology; Panel A), GRE#1 or GRE#1 mutant (Panel B) mutant, GRE#2 or
GRE#2 mutant (Panel C). For samples in Panels A-C, Lane 1 is probe only, Lane 2 is probeþcell lysate, Lane 3 is probeþcell lysate (DEX treated), Lane 4 is probeþcell lysate
(transfected with GR), and Lane 5 is probeþcell lysate (transfected with GR and treated with DEX). Arrows or closed circles denote shifted bands. Competition assays were
performed to examine the speciﬁcity of binding to the radioactive probe (GRE#1). Increasing concentrations of “cold” GRE#1, GRE#1 mutant (Panel D), or the consensus GRE
(Panel E) were used for these studies. Lane 1 was only radioactive probe (no cell lysate) and lane 2, radioactive probeþcell lysate treated with 10 μM DEX. Lanes 3–8
contained increasing concentrations of the designated non-radioactive oligonucleotides (6, 15, 30, 60, 120, or 300 pmol, respectively). These results are representative of two
independent experiments.
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plasmids were transfected into Neuro-2A cells using TransIT-
Neural (Mirus, Madison, WI), according to manufacturer’s inst-
ructions.
A BHV-1 mutant containing the β-Gal gene in place of the viral gC
gene was obtained from S. Chowdury (LSU School of Veterinary
Medicine) (gCblue virus). This virus grows to similar titers as the wild
type parent virus and expresses the Lac Z gene. Primary bovine kidney
(BK) cells were cotransfected with gCblue viral DNA using Lipofecta-
mine 2000 (Invitrogen). β-Galactosidase (β-Gal) positive cells were
counted at 24 h after transfection as described previously (Geiser
et al., 2002; Inman et al., 2001a, 2001b, 2002b). The number of β-
Galþ cells in cultures transfected with gCblue genomic DNA reﬂect
the number of plaques (Geiser et al., 2002; Inman et al., 2001a, 2001b,
2002b); and this value was set at 1 for each experiment. The effect
that DEX and expression of the GR had on productive infection is
expressed as fold induction relative to the control. This representation
of the data minimizes differences in cell density, variation in Lipo-
fectamine 2000 lots, and transfection efﬁciency.
Plasmids
pIE1 (IEtu1cat), pIE1Δ831 (IEtu1catΔ831), and pIE1Δ1018 (IEtu1-
catΔ1018) were obtained from VickramMisra (University of Saskatch-
ewan) and were described previously (Misra et al., 1994, 1995). The
BHV-1 VP16 promoter contains sequences that span 547 to þ207
from the initiating ATG of the VP16 ORF. A fragment containing the
core IEtu2 promoter (348 to þ33) was described in an earlier
publication (Koppel et al., 1997). VP16 and IEtu2 promoter fragments
were synthesized by Integrated DNA Technology (IDT; Coralville, Iowa)
and they contain a unique KpnI at the their 50 terminus as well as a
XhoI site at their 30 terminus. The respective promoters were cloned
into the chloramephenicol acetyltransferase (CAT) promoter minus
vector (pCAT3-Basic Vector; Promega) at the unique KpnI and XhoI
restriction enzyme sites.
The IEtu1 DRR enhancer constructs are summarized in Fig. 3B and
were prepared as described below. The DRR contains sequences from
the SphI site to the Δ831 50-terminus. The 50-DRR contains the 50 415
base pairs of the DRR. The 30-DRR contains 416 base pair of the 30 end
of the DRR. The 30-DRRΔGRE#1 contains an EcoRI restriction enzyme
site in place of GRE#1 and lacks key nucleotides in the consensus GRE
(Fig. 4C). The 30-DRRΔGRE#2 contains an EcoRI restriction enzyme
site in place of GRE#2 and lacks key nucleotides in the consensus GRE
(Fig. 3C). The 30-DRRΔ2xGRE lacks both GRE#1 and GRE#2. All of
these constructs were synthesized by IDT, contain unique KpnI and
XhoI restriction sites at their 50 and 30 termini respectively and were
cloned into the same restriction enzyme sites of pCAT3-Promoter
Fig. 5. The GR interacts with the IEtu1 promoter in transfected cells. Panel A:
Schematic of IEtu1 promoter shown in Fig. 2A. Primer pairs used for ChIP assays are
denoted. GR1x and GR2x have a common forward primer but a unique reverse
primer. The TATA primer was previously described (Meyer and Jones, 2008). Panel
B: As described in materials and methods, Neuro-2A cells were cotransfected with
the IEtu1cat plasmid or IEtu1catΔ831 construct lacking GREs as a negative control.
The GR expression plasmid was included in the transfection and designated
cultures were treated with DEX as described above. Neuro-2A cells transfected
with no plasmid is designated as mock. Transfected cells were processed for ChIP as
described in the materials and methods using the GR speciﬁc antibody from Cell
Signaling. Lane 1 was ampliﬁed with GRE1x primers, lane 2 was ampliﬁed with
GRE2x primers, and lane 3 was ampliﬁed with TATA primers. Panel C: GREþ IE1
and GREþ IE1 DEX samples were immunoprecipitated with an isotype control
antibody and then ChIP using the same primers described in Panel B. Panel D: Input
denotes 10% of the total DNA: protein complexes used for IP was used for PCR using
the designated PCR primers. Location of respective PCR products (244, 255, 543)
and primer dimer (pd) are denoted on the left side of the gel. These results are
representative of three independent studies.
Fig. 6. Examination of GR in Neuro-2A cells. Panel A: Neuro-2A cells or Neuro-2A
cells transfected with 1.5 μg DNA of the plasmid encoding the human GR were
treated with water-soluble DEX 24 h after transfection. Forty-eight hours later, total
cell lysate was prepared and GR levels measured using a speciﬁc GR antibody (Cell
Signaling; 3660). The designated concentrations of protein in cell lysate were used
for Western blot analysis. Western blots were cut and then probed with a tubulin
antibody as a loading control. Migration of endogenous GR and GR-GFP fusion
protein (closed circle) are denoted. Panel B: Confocal analysis of GR localization in
Neuro-2A cells following treatment with stripped FBS and DEX treatment. Confocal
microscopy was performed as previously described (Frizzo da Silva et al., 2013).
Nuclear DNA was stained with DAPI (top panel). Bottom panel is merge of DAPI
stained nucleus and GR staining (green). Brackets denote size in microns.
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vector (Promega). The pCAT3-Promoter vector contains a minimal
SV40 early promoter linked to CAT and the respective IEtu1 promoter
sequences are cloned upstream of the SV40 early promoter.
A mouse GR expression vector was obtained from Dr. Joseph
Cidlowski, NIH. A human GR expression vector was used for certain
studies and was obtained from Addgene (pk7-GR-GFP), which was
provided by Dr. Ian McKara, U of Vermont. The human GR ORF is
fused with GFP, which allowed monitoring of subcellular levels of GR
in transfected cells prior to DEX treatment. All plasmids were
prepared from bacterial cultures by alkaline lysis and 2 rounds of
cesium chloride centrifugation.
Measurement of CAT activity
Neuro-2A cells grown in 60mm dishes were co-transfected with
the designated plasmids as indicated in the respective ﬁgure legends
using NeuroTransIt (MIR2145; Mirus). After 5 h of transfection, cells
were incubated in EMEM supplemented with 2% charcoal stripped
fetal bovine serum (Gibco). As designated, cultures were treated with
10 μMwater-soluble DEX (Sigma) for 24 h prior to harvesting cells. At
48 h after transfection, cell extract was prepared by three freeze/thaw
cycles in 0.25 M Tris–HCl, pH 7.4. Cell debris was pelleted by
centrifugation, and protein concentrations determined. CAT activity
was measured by incubating with 0.1 μCi (14C)-chloramphenicol
(CFA754; Amersham Biosciences) and 0.5 mM AcetylCoA (A2181;
Sigma). The reaction was incubated at 37 1C for 5 to 30 min. All forms
of chloramphenicol were separated by thin-layer chromatography.
CAT activity was quantiﬁed using a Bio-Rad Molecular Imager FX
(Molecular Dynamics, CA) and is expressed as fold induction of
samples containing DEX relative to no DEX treatment.
Electrophoretic mobility shift assay (EMSA)
Neuro-2A whole-cell lysate was prepared by lysing cells with
NP-40 lysis buffer {50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1% NP-
40 and protease inhibitor (78430; Thermo scientiﬁc)}. Oligonu-
cleotides were labeled with γ-32P-ATP using T4 polynucleotide
kinase (M0201S; New England Biolabs) and puriﬁed using chro-
matography columns (732–6006; Bio-Rad). Thirty micrograms of
protein extract was incubated in 4 μl of 5 binding buffer (50 mM
Tris–HCl, pH 8, 750 mM KCl, 2.5 mM EDTA, 0.5% Triton X-100,
62.5% glycerol and 1 mM DTT) in the presence of 1 μg poly(dI-dC)
(MB788003; Thermo scientiﬁc) and double-stranded DNA probe
labeled at its 50-termini using γ-32P-ATP. Incubation was for 1 h at
room temperature. For competition assays, unlabeled double
stranded oligonucleotides were incubated with the reaction mix-
ture at room temperature for 20 min prior to additions to
radiolabeled probe. DNA-protein complexes were electrophoresed
on a 5% polyacrylamide gel in 0.5 Tris-borate-EDTA buffer for
3 h at 100 V. Radioactive bands on the gel were analyzed using a
Bio-Rad Molecular Imager FX. GRE probes used for EMSA are listed
below:
GRE#1, GGCTTGAAGGAACACTGTGTTCCTCGCATA,
GRE#1 mutant, GGCTTGAAGGAATTCTCGCATTATCGCATA,
GRE#2, GGCAACTGGTACACTGTGTGGCGATCTCGC,
GRE#2 mutant, GGCAACTGGAATTCGGCGTTCTGATCTCGC,
GRE consensus oligonucleotide, GACCCTAGAGGATCTGTACAG-
GATGTTCTAGAT, (Santa Cruz, sc-2545), and
GRE mutant oligonucleotide, GACCCTAGAGGATCTCAACAGGAT-
CATCTAGAT (Santa Cruz, sc-2546).
Western blot analysis
Neuro-2A cells were scraped from dishes, cells washed with
PBS, and lysed with NP-40 lysis buffer (50 mM Tris–HCl, pH 8.0,
150 mM NaCl, 1% NP-40 and protease inhibitor {78430; Thermo
scientiﬁc}). For SDS-PAGE, proteins were mixed with 5 sample
loading buffer (0.2 M Tris–HCl {pH 6.8}, 10% sodium dodecyl
sulfate, 10 mM merchaptoethanol, 0.05% bromophenol blue, 20%
glycerol) and boiled for 5 min. Proteins were separated in a 10%
SDS-PAGE gel. After electrophoresis, proteins were transferred
onto a polyvinylidene diﬂuoride membrane (Bio-Rad) and blocked
for 2 h at room temperature in 5% nonfat dry milk with Tris-
buffered saline-0.1% Tween 20 (TBS-T). Membranes were then
incubated with primary antibody for 2 h at 4 1C. An antibody
directed against β-tubulin (Sigma) was used as a loading control.
After 45 min washing with TBS-T, blots were incubated with
donkey anti-rabbit horseradish peroxidase-conjugated immuno-
globulin G (Amersham Biosciences), which was diluted 1:2000 in
5% nonfat milk in TBS-T. Blots were washed 45 min with TBS-T,
exposed to Amersham ECL reagents, and then autoradiography
performed. Primary antibodies are described above. The GR
primary antibody (Cell Signaling; 3660) was diluted 1:1000. The
secondary donkey anti-rabbit and anti-mouse antibodies were
purchased from GE Healthcare.
Glucocorticoid receptor binding site identiﬁcation
The genomic sequence for Bovine herpesvirus 1.1 Cooper Strain,
GenBank accession number JX898220.1, was analyzed for GR-
binding sites using AliBaba 2.1 software, which is available at
www.generegulation.com. This software uses the TRANSFAC data-
base (Matys et al., 2006).
Chromatin immunoprecipitation (ChIP) assay
Neuro-2A cells were washed with phosphate-buffered saline (PBS)
and suspended in 50 ml of medium with no serum. A volume of
1.35 ml of 37% formaldehyde was added for cross-linking and the cell
suspension was allowed to gently shake at 20 1C for 15 min. Cross-
linking was stopped by addition of 2.5 ml of 2.5 M glycine and then
incubating at 48 1C for 5 min. Cells were pelleted by centrifuging at
1000 g followed by two washes with ice-cold PBS that contained
1mM phenylmethylsulfonyl sluoride (PMSF). The ﬁnal pellet was
suspended in 3 ml of cell lysis buffer (5 mM PIPES pH 8, 85 mM KCl,
0.5% Nonidet P40 {NP40}) and incubated on ice for 10 min. Cells were
vortexed every 2 min to promote lysis. Crude nuclei were pelleted and
suspended in 3 ml of nuclear lysis buffer (50 mM Tris–HCl pH 8.1,
10 mM EDTA, 1% sodium dodecyl sulfate {SDS}) and incubated on ice
for 10 min. The suspension was then sonicated three times for 30 s on
ice. Sonicated samples were divided into two tubes and diluted to
10 ml with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM
EDTA, pH 8, 16.7 mM Tris–HCl, pH 8.1, 167 mM NaCl, 1 mM PMSF).
Samples were pre-cleared by adding 75 ml of agarose/salmon sperm
DNA protein A beads (Upstate) and incubating for 1 h at 4 1C. Agarose
beads were removed by centrifugation and 10mg of GR antibody (Ab)
was added. A tube that contained an isotype control IgG (I8140;
Sigma) was used as a control for speciﬁc binding to the GR antibody.
Tubes were incubated overnight at 48 1C, and samples were con-
tinuously rotated. Seventy-ﬁve microliters of agarose protein A beads
were added the next morning and allowed to incubate at 48 1C. Beads
were pelleted and washed with 1 ml of each of the following buffers:
low-salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, pH 8,
20 mM Tris–HCl, pH 8.1, 150 mM NaCl), high salt wash buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, pH 8, 20 mM Tris–HCl, pH 8.1,
500 mM NaCl), LiCl wash buffer (0.25 M LiCl, 1% NP40, 1% sodium
deoxycholate, 1 mM EDTA, pH 8), and TE buffer (10 mM Tris–HCl,
1 mM EDTA, pH 8). DNA-protein complexes were eluted from beads
by incubating with 500 μl of elution buffer (1% SDS, 0.1 M NaHCO3)
and vortexing gently for 15 min at room temperature. Agarose beads
were centrifuged and the supernatant transferred to another tube.
Twenty microliters of 5 M NaCl was added to each tube and placed in
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a water bath at 65 1C overnight to de-cross-link proteins from DNA.
Samples were then extracted once with phenol:chlorophorm:isoamyl
alcohol and once with chloroform. DNAwas precipitated with isoamyl
alcohol, washed with 70% ethanol, dried in a vacuum microfuge, and
suspended in 30 to 50 μl of water. Polymerase chain reaction (PCR)
was then performed using primers described below and in Fig. 6:
GR forward: TCCCCGCTTTTGTTATCG
GR 1x reverse: CCCTACTTTTGCCTGTGTG
GR 2x reverse: GGCATTTAGTTTTGGTGGTTGG
TATA forward: CGGCCATGCTTTCATGCAAATGAGCCCCGACAGCC
TATA reverse: AGCAGCGGCAGCGGCAGGTGTTGCAGTACGGGTGT
All primers are 50-30.
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